The BA receptor FXR is known to regulate glucose metabolism [2] and the FXR agonist OCA, an analogue of CDCA, has been demonstrated to improve insulin sensitivity in patients with type 2 diabetes mellitus [29]. This evidence concerns the gene NR1H4 and type 2 diabetes mellitus.